{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:16:09Z","timestamp":1776208569290,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100006044","name":"Astellas Pharma Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006044","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourol. Urodynam."],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1002\/nau.22808","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T18:37:13Z","timestamp":1437503833000},"page":"819-825","source":"Crossref","is-referenced-by-count":20,"title":["Bladder wall thickness in women with symptoms of overactive bladder and detrusor overactivity: Results from the randomised, placebo-controlled shrink study"],"prefix":"10.1002","volume":"35","author":[{"given":"Dudley","family":"Robinson","sequence":"first","affiliation":[{"name":"King's College Hospital; London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Oelke","sequence":"additional","affiliation":[{"name":"Hannover Medical School; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vik","family":"Khullar","sequence":"additional","affiliation":[{"name":"St Mary's Hospital; Imperial College; London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hessel","family":"Wijkstra","sequence":"additional","affiliation":[{"name":"Academic Medical Center University Hospital; Amsterdam and Eindhoven University of Technology; The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Tretter","sequence":"additional","affiliation":[{"name":"Astellas Pharma Europe B.V.; Leiden The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Stow","sequence":"additional","affiliation":[{"name":"Astellas Pharma Europe; Chertsey United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Compion","sequence":"additional","affiliation":[{"name":"Formerly of Astellas Pharma Europe; Chertsey United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Tubaro","sequence":"additional","affiliation":[{"name":"La Sapienza University of Rome; Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"key":"10.1002\/nau.22808-BIB0001|nau22808-cit-0001","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22808-BIB0002|nau22808-cit-0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22808-BIB0003|nau22808-cit-0003","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","article-title":"EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"64","author":"Oelke","year":"2013","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22808-BIB0004|nau22808-cit-0004","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.eururo.2012.08.047","article-title":"EAU guidelines on assessment and nonsurgical management of urinary incontinence","volume":"62","author":"Lucas","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22808-BIB0005|nau22808-cit-0005","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/382431","article-title":"Biomarkers in overactive bladder: A new objective and noninvasive tool?","author":"Antunes-Lopes","year":"2011","journal-title":"Adv Urol"},{"key":"10.1002\/nau.22808-BIB0006|nau22808-cit-0006","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/nau.1930130510","article-title":"Ultrasound diagnosis of bladder outlet obstruction in rabbits","volume":"13","author":"Schoor","year":"1994","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22808-BIB0007|nau22808-cit-0007","first-page":"S35","article-title":"The effect of bladder outlet obstruction treatment on ultrasound-determined bladder wall thickness","volume":"7","author":"Tubaro","year":"2005","journal-title":"Rev Urol"},{"key":"10.1002\/nau.22808-BIB0008|nau22808-cit-0008","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eururo.2008.02.017","article-title":"Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia","volume":"54","author":"Oelke","year":"2008","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22808-BIB0009|nau22808-cit-0009","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1471-0528.1996.tb09910.x","article-title":"Ultrasound: A noninvasive screening test for detrusor instability","volume":"103","author":"Khullar","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1002\/nau.22808-BIB0010|nau22808-cit-0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1471-0528.2002.01021.x","article-title":"Can ultrasound replace ambulatory urodynamics when investigating women with irritative urinary symptoms?","volume":"109","author":"Robinson","year":"2002","journal-title":"BJOG"},{"key":"10.1002\/nau.22808-BIB0011|nau22808-cit-0011","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00192-010-1194-1","article-title":"Ultrasound measurement of bladder wall thickness in different forms of detrusor overactivity","volume":"21","author":"Serati","year":"2010","journal-title":"Int Urogynecol J"},{"key":"10.1002\/nau.22808-BIB0012|nau22808-cit-0012","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/nau.20997","article-title":"Sonographic transvaginal bladder wall thickness: Does the measurement discriminate between urodynamic diagnoses?","volume":"30","author":"Kuhn","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22808-BIB0013|nau22808-cit-0013","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00345-013-1030-6","article-title":"Review on ultrasound measurement of bladder or detrusor wall thickness in women: Techniques, diagnostic utility, and use in clinical trials","volume":"31","author":"Oelke","year":"2013","journal-title":"World J Urol"},{"key":"10.1002\/nau.22808-BIB0014|nau22808-cit-0014","unstructured":"Khullar V Hill S Cardozo L"},{"key":"10.1002\/nau.22808-BIB0015|nau22808-cit-0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00192-010-1123-3","article-title":"Is the beneficial effect of antimuscarinics related to motor or sensory changes in the bladder?","volume":"21","author":"Panayi","year":"2010","journal-title":"Int Urogynecol J"},{"key":"10.1002\/nau.22808-BIB0016|nau22808-cit-0016","first-page":"327","article-title":"Bladder wall thickness: An objective measure of drug efficacy?","volume":"5","author":"Khullar","year":"1994","journal-title":"Int Urogynecol J"},{"key":"10.1002\/nau.22808-BIB0017|nau22808-cit-0017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/nau.20110","article-title":"Test-retest reliability of four questionnaires for patients with overactive bladder: The overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ)","volume":"24","author":"Matza","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22808-BIB0018|nau22808-cit-0018","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1016370925601","article-title":"Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q","volume":"11","author":"Coyne","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1002\/nau.22808-BIB0019|nau22808-cit-0019","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1464-410X.2008.07769.x","article-title":"A review of adherence to drug therapy in patients with overactive bladder","volume":"102","author":"Basra","year":"2008","journal-title":"BJU Int"},{"key":"10.1002\/nau.22808-BIB0020|nau22808-cit-0020","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12194","article-title":"Mirabegron for the treatment of overactive bladder: A prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies","author":"Nitti","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.1002\/nau.22808-BIB0021|nau22808-cit-0021","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1002\/nau.22808-BIB0022|nau22808-cit-0022","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.5489\/cuaj.1513","article-title":"The relationship between bladder wall thickness and lower urinary tract symptoms: Does bladder wall thickness change after alpha-blocker therapy with alfuzosin?","volume":"8","author":"Karakose","year":"2014","journal-title":"Can Urol Assoc J"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22808","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22808","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/nau.22808\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T21:04:12Z","timestamp":1625346252000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.22808"}},"subtitle":["Bladder Wall Thickness In Women"],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1002\/nau.22808","archive":["Portico"],"relation":{},"ISSN":["0733-2467"],"issn-type":[{"value":"0733-2467","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7,21]]}}}